par Luc St-Pierre | Oct 31, 2018 | Non classé
PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition Vancouver, British Columbia–(Newsfile Corp. – October 31, 2018) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:...
par Luc St-Pierre | Oct 31, 2018 | Non classé
WeedMD Signs Multi-year Retail Sales Distribution Deal with Lifford Cannabis Solutions TORONTO, Oct. 31, 2018 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of...
par Luc St-Pierre | Oct 31, 2018 | Non classé
BELLUS Health Announces Issuance of New U.S. Patent Claiming P2X3 Selectivity as a Means of Minimizing Taste Effects for its Lead Chronic Cough Drug Candidate BLU-5937 – New Patent Extends BLU-5937’s Patent Protection to 2038 – – Expands...
par Luc St-Pierre | Oct 30, 2018 | Non classé
PreveCeutical Holds Intensive Workshop to Advance Dual Gene Therapy Research Program for Type 2 Diabetes and Obesity Vancouver, British Columbia–(Newsfile Corp. – October 30, 2018) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:...
par Luc St-Pierre | Oct 30, 2018 | Non classé
Future Farm Announces NexTech’s CSE Trading Date of October 31, 2018 Vancouver, British Columbia, Oct. 30, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Future Farm Technologies Inc. (“Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that...
